Abbott obtains additional clearance in planned merger with Advanced Medical Optics

By Lisa Kerner

Charlotte, N.C., Feb. 20 - The European Commission granted merger control clearance in Abbott Laboratories' proposed acquisition of Advanced Medical Optics, Inc.

Abbott previously announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 had ended.

On Jan. 12, Abbott announced it would acquire Advanced Medical Optics for $2.8 billion, including net debt.

Abbott's $22-per-share cash tender offer for Advanced Medical Optics is set to end at midnight ET on Feb. 24. The offer began on Jan. 27.

Santa Ana, Calif.-based Advanced Medical Optics operates in three segments: cataract surgery, Lasik and eye-care products.

Abbott is a biopharmaceutical company located in Abbott Park, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.